Results 151 to 160 of about 8,324,430 (306)

ESR1 methylation and ESR1 mutations in circulating tumor cells (CTCs) and paired plasma‐cfDNA of advanced breast cancer patients: A feasibility proof‐of‐concept study

open access: yesMolecular Oncology, EarlyView.
Circulating tumor cells (CTCs) and plasma cell‐free DNA (cfDNA) were analyzed to detect ESR1 mutations and methylation in patients with advanced breast cancer. CTC‐derived DNA showed higher sensitivity for mutation detection and revealed complementary genetic and epigenetic alterations, highlighting the added value of CTC analysis for understanding ...
Dimitra Stergiopoulou   +12 more
wiley   +1 more source

Nursing student's experiences of taking part in a Death Café: A qualitative study. [PDF]

open access: yesPalliat Care Soc Pract
Malumbres-Talavera J   +6 more
europepmc   +1 more source

Screening for cardiac conditions associated with sudden cardiac death in the young : external review against programme appraisal criteria for the UK National Screening Committee [PDF]

open access: yes, 2019
Bradlow, William   +8 more
core  

Harry Potter and the Meaning of Death

open access: yes, 2017
The paper reviews how J.K. Rowling is able to examine death in the Harry Potter book series. In the first part of the text the author touches on the deaths of Harry\u27s parents and the scarring that Harry receives from that, as well as an examination of
Brown, Harrison D.
core  

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

open access: yesMolecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata   +10 more
wiley   +1 more source

Molecular cancer prevention: Intercepting disease

open access: yesMolecular Oncology, Volume 20, Issue 6, Page 1392-1397, June 2026.
Oncological practice must evolve, from treating established tumours to proactive cancer interception before clinical manifestation. This will require mechanistic insight into tumour initiation, validated biomarkers of early disease development and redesigned clinical trials, enabling cancer interception to become a core pillar of oncology with the ...
Charlotte Grieco   +2 more
wiley   +1 more source

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

open access: yesMolecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary   +1 more
wiley   +1 more source

N501Y mutation imparts cross-species transmission of SARS-CoV-2 to mice by enhancing receptor binding

open access: yesSignal Transduction and Targeted Therapy, 2021
Zubiao Niu   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy